NCT06233071View on ClinicalTrials.gov

Drospirenone (3 mg) + Ethinyl Estradiol (0.02 mg) Tablets Relative to Yaz®

PHASE1RecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 13, 2024

Primary Completion Date

April 4, 2024

Study Completion Date

May 2, 2024

Conditions
Healthy Subjects
Interventions
DRUG

Drospirenone+ Ethinyl Estradiol Tablets-Test product

Drospirenone (3 mg) + Ethinyl Estradiol (0.02 mg) Tablets Manufactured by: POND'S CHEMICAL THAILAND R.O.P

DRUG

Drospirenone+ Ethinyl Estradiol Tablets-Reference product

Drospirenone (3 mg) + Ethinyl Estradiol (0.02 mg) Tablets Manufactured by: Bayer Weimar GmbH und Co. KG, Germany

Trial Locations (1)

10110

RECRUITING

Bio-innova, Bangkok

All Listed Sponsors
lead

Bio-innova Co., Ltd

INDUSTRY